Cryptococcal Meningitis

• FDA approval · 2010-03-05
  FDA Approved: AMPHOTERICIN B — Supplemental Application (XGen Pharmaceuticals DJB, Inc.)

  FDA approved a supplemental application for Amphotericin B submitted by XGen Pharmaceuticals DJB, Inc. This approval authorizes a change to …

• FDA approval · 2009-09-18
  FDA Approved: FLUCONAZOLE — Original Application (Rising Pharma Holdings, Inc.)

  FDA approved the original application for fluconazole from Rising Pharma Holdings, Inc., enabling the generic antifungal to enter the market…

• FDA approval · 2009-07-30
  FDA Approved: FLUCONAZOLE — Original Application (Hospira, Inc)

  FDA approved Hospira's original application for a generic fluconazole product, an antifungal medication with indications similar to the refe…

• FDA approval · 2006-08-10
  FDA Approved: ANCOBON — Supplemental Application (Bausch Health US LLC)

  FDA approved a supplemental application for ANCOBON (flucytosine) submitted by Bausch Health US LLC.